Operating income increased 375.1%
Operating income changed +375.1% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed +375.1% from the comparable as-filed period.
Inventory changed -12.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed +551 basis points from the comparable as-filed period.
Gross margin changed +548 basis points from the comparable as-filed period.
Trade receivables changed -21.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Revenue changed -25.0% from the comparable as-filed period.
Free-cash-flow proxy changed -27.0% from the comparable as-filed period.
Operating cash flow changed -27.7% from the comparable as-filed period.
Research & development changed -37.6% from the comparable as-filed period.
Shares outstanding changed -3.4% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
Inventory / revenue changed +1355 basis points from the comparable as-filed period.
Stock-based compensation changed -68.4% from the comparable as-filed period.
Receivables / revenue changed +384 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Capital expenditure changed -32.2% from the comparable as-filed period.
Working capital / assets changed +466 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Current liabilities changed -17.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Selling, general & administrative changed -21.0% from the comparable as-filed period.
Total assets changed -12.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Current assets changed -10.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
SBC / revenue changed -98 basis points from the comparable as-filed period.
Cash & equivalents changed -5.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Capex / revenue changed -12 basis points from the comparable as-filed period.
Gross profit changed -11.3% from the comparable as-filed period.
Current ratio changed +9.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
R&D / revenue changed -120 basis points from the comparable as-filed period.
Working capital changed +2.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Operating cash-flow margin changed -32 basis points from the comparable as-filed period.
Free-cash-flow margin changed -20 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.